Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700028968

Trial Profile

Clinical Trials Insight: 700028968

Phase of Trial: Phase I/II

Latest Information Update: 12 Jan 2010

At a glance

  • Drugs Glucagon-like peptide-1 (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Sponsors Biocompatibles International
  • Most Recent Events

    • 12 Jan 2010 Completion of patient enrolment now expected in 2010. Six patients have been recruited and recruitment of the remaining 14 patients is expected by end of 2010, according to a Biocompatibles International media release.
    • 30 Nov 2007 Completion of patient enrolment expected in 2008.
    • 30 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top